S Rofagha, RB Bhisitkul, DS Boyer,
SVR Sadda… - Ophthalmology, 2013 - Elsevier
Purpose To assess long-term outcomes 7 to 8 years after initiation of intensive ranibizumab
therapy in exudative age-related macular degeneration (AMD) patients. Design Multicenter …